Exploring the Binding Modes of Quinazolinone-1,2,4-Triazole Hybrids on PARP-10 Inhibition for Anti-Neoplastic Therapy: Docking and ADME Studies
Ruchi Shakya(Indo Soviet Friendship College of Pharmacy), Preeti Patel(Indo Soviet Friendship College of Pharmacy), Sakshi Priya(ITRI International), Balak Das Kurmi(Indo Soviet Friendship College of Pharmacy), Shivani Kasana(Indo Soviet Friendship College of Pharmacy), Md. Shafiqul Islam(Indo Soviet Friendship College of Pharmacy)
International Journal of Medical Pharmaceutical and Health Sciences (IJMPHS).
October 3, 2024
Cited by 8
Related Papers
Solid lipid nanoparticles: a review on recent perspectives and patents
|Expert Opinion on Therapeutic Patents|2020|323
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
|ACS Omega|2022|207
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|206
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|138
Micro- and nanocarrier-mediated lung targeting
|Expert Opinion on Drug Delivery|2010|121